Founded in Izmir, Turkey, in 1996, Disera initially specialized in laboratory consumables. Through persistent innovation, it quickly became a global leader in blood collection tube manufacturing.
In 2019, Disera launched its proprietary PRP tubes, marking a significant entry into the aesthetics market.
Since 2024, Disera has advanced regenerative applications under its new brand, Vacusera Biostimulants, dedicated to pioneering scientific approaches in regenerative medicine and surgery.
Vacusera Biostimulants is a game-changer in the biostimulant field, achieving outstanding results with a groundbreaking portfolio, including:
Adinizer kits for mechanical stromal cell isolation.
PEXT, the world’s only exosome verified and proven quality by intracellular glutathione.
Exera autologous exosome kits.
Pioneering peptides offering the world's first combination of botox-like and retinoic acid-like effects.
A Next-generation cellular revitalizer with optimal PDRN/PN and glutathione.
Next-gen EVs.